If these numbers worry you, it’s important to know what those expenses are so you can take steps to get ready and have the funds to pay when the time comes.

Medicare is negotiating to lower the price of several major drugs aimed at treating chronic conditions, cancers, and autoimmune treatments.

With appreciation for feedback from Mark Fendrick, Director of the Value-Based Insurance Design (V-BID) Center at the ...

The Centers for Medicare and Medicaid Services said Tuesday it seeks to lower Medicare costs for 16 medications by ...

Medicaid cuts and lapsed subsidies could swell the uninsured, pushing west-central Illinois hospitals to spend more on ...

More than one million fewer Americans are now covered compared to the record-high 24 million people who enrolled in Obamacare ...

Selling your home just before you qualify for Medicare isn’t a solution. The Social Security Administration (SSA) generally ...

President Donald Trump and the Centers for Medicare & Medicaid Services (CMS) recently announced the 15 drugs whose prices ...

Medicare selected Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower ...

List includes medications for diabetes, cancer, arthritis, and more ...

The U.S. government on Tuesday named the 15 new drugs targeted for Medicare price negotiations for 2028, including Gilead ...

The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...